Erzurum Regional Training and Research Hospital, Turkey.
Pain Physician. 2020 Nov;23(6):581-588.
Suprascapular nerve block (SSNB) is an effective therapeutic approach for shoulder pain and has been increasingly used by professionals in clinical practice. In the landmark-guided nerve block technique, it could be difficult to determine the exact localization of the suprascapular nerve.
To evaluate and compare the clinical and functional outcomes of ultrasound (US)-guided versus landmark-guided SSNB for the treatment of chronic shoulder pain.
Randomized, prospective analysis.
Outpatient physical therapy and rehabilitation clinic.
Seventy-two patients with chronic shoulder pain were enrolled into this study. The patients were randomly allocated to 2 groups. Thirty-six patients received US-guided SSNB and 36 underwent landmark-guided SSNB. Initial examinations before injection and for the first week and first and third months postinjection were recorded. Visual Analog Scale (VAS) pain intensity levels, shoulder functions based on the Shoulder Pain and Disability Index (SPADI), and quality of life levels based on the Health Assessment Questionnaire (HAQ) were evaluated at each control.
Statistically significant recovery was observed in terms of VAS pain levels, SPADI, and HAQ from the first week after injection in both groups, but no significant difference was observed between the groups.
The absence of a control group.
Our results indicate that US-guided SSNB does not potentially offer a significantly greater clinical improvement over landmark-guided SSNB in patients with chronic shoulder pain. Further research is required to establish whether this hypothesis is consistently supported in practice.
肩胛上神经阻滞(SSNB)是一种治疗肩部疼痛的有效方法,在临床实践中越来越多的专业人员在使用。在路标引导的神经阻滞技术中,确定肩胛上神经的确切位置可能具有挑战性。
评估和比较超声(US)引导与路标引导 SSNB 治疗慢性肩部疼痛的临床和功能结果。
随机、前瞻性分析。
门诊物理治疗和康复诊所。
本研究纳入了 72 例慢性肩部疼痛患者。患者被随机分配到 2 组。36 例患者接受 US 引导的 SSNB,36 例患者接受路标引导的 SSNB。在注射前、注射后第 1 周和第 1、3 个月进行初始检查。在每次随访时评估视觉模拟量表(VAS)疼痛强度水平、基于肩痛和残疾指数(SPADI)的肩部功能以及基于健康评估问卷(HAQ)的生活质量水平。
两组患者在注射后第 1 周 VAS 疼痛水平、SPADI 和 HAQ 均有显著恢复,但组间无显著差异。
缺乏对照组。
我们的结果表明,在慢性肩部疼痛患者中,US 引导的 SSNB 并没有比路标引导的 SSNB 带来明显更大的临床改善。需要进一步的研究来确定这一假设在实践中是否得到一致支持。